. 2024 Oct 26;12(30):6361–6373. doi: 10.12998/wjcc.v12.i30.6361
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
Figure 2.
Summary of characteristics and treatments for demyelinating diseases.